Literature DB >> 28795464

Antimicrobial activity of leucine-substituted decoralin analogs with lower hemolytic activity.

Marcelo Der Torossian Torres1, Cibele Nicolaski Pedron1, Julia Aparecida da Silva Lima1, Pedro Ismael da Silva2, Fernanda Dias da Silva1, Vani Xavier Oliveira1.   

Abstract

Linear cationic α-helical antimicrobial peptides are promising chemotherapeutics. Most of them act by different mechanisms, making it difficult to microorganisms acquiring resistance. Decoralin is an example of antimicrobial peptide; it was described by Konno et al. and presented activity against microorganisms, but with pronounced hemolytic activity. We synthesized leucine-substituted decoralin analogs designed based on important physicochemical properties, which depend on the maintenance of the amphiphilic α-helical tendency of the native molecule. Peptides were synthesized, purified, and characterized, and the conformational studies were performed. The results indicated that the analogs presented both higher therapeutic indexes, but with antagonistic behavior. While [Leu]10 -Dec-NH2 analog showed similar activity against different microorganisms (c.a. 0.4-0.8 μmol L-1 ), helical structuration, and some hemolytic activity, [Leu]8 -Dec-NH2 analog did not tend to helical structure and presented antimicrobial activities two orders higher than the other two peptides analyzed. On the other hand, this analog showed to be the less hemolytic (MHC value = 50.0 μmol L-1 ). This approach provided insight for understanding the effects of the leucine substitution in the amphiphilic balance. They led to changes on the conformational tendency, which showed to be important for the mechanism of action and affecting antimicrobial and hemolytic activities.
Copyright © 2017 European Peptide Society and John Wiley & Sons, Ltd. Copyright © 2017 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Keywords:  antimicrobial peptide; decoralin; leucine-substituted peptides; structure-activity relationship

Mesh:

Substances:

Year:  2017        PMID: 28795464     DOI: 10.1002/psc.3029

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  5 in total

1.  Structure-function-guided exploration of the antimicrobial peptide polybia-CP identifies activity determinants and generates synthetic therapeutic candidates.

Authors:  Marcelo D T Torres; Cibele N Pedron; Yasutomi Higashikuni; Robin M Kramer; Marlon H Cardoso; Karen G N Oshiro; Octávio L Franco; Pedro I Silva Junior; Fernanda D Silva; Vani X Oliveira Junior; Timothy K Lu; Cesar de la Fuente-Nunez
Journal:  Commun Biol       Date:  2018-12-07

Review 2.  Chemical and Biological Characteristics of Antimicrobial α-Helical Peptides Found in Solitary Wasp Venoms and Their Interactions with Model Membranes.

Authors:  Marcia Perez Dos Santos Cabrera; Marisa Rangel; João Ruggiero Neto; Katsuhiro Konno
Journal:  Toxins (Basel)       Date:  2019-09-24       Impact factor: 4.546

3.  Natural and redesigned wasp venom peptides with selective antitumoral activity.

Authors:  Marcelo D T Torres; Gislaine P Andrade; Roseli H Sato; Cibele N Pedron; Tania M Manieri; Giselle Cerchiaro; Anderson O Ribeiro; Cesar de la Fuente-Nunez; Vani X Oliveira
Journal:  Beilstein J Org Chem       Date:  2018-07-06       Impact factor: 2.883

Review 4.  Wasp Venom Biochemical Components and Their Potential in Biological Applications and Nanotechnological Interventions.

Authors:  Aida Abd El-Wahed; Nermeen Yosri; Hanem H Sakr; Ming Du; Ahmed F M Algethami; Chao Zhao; Ahmed H Abdelazeem; Haroon Elrasheid Tahir; Saad H D Masry; Mohamed M Abdel-Daim; Syed Ghulam Musharraf; Islam El-Garawani; Guoyin Kai; Yahya Al Naggar; Shaden A M Khalifa; Hesham R El-Seedi
Journal:  Toxins (Basel)       Date:  2021-03-12       Impact factor: 4.546

Review 5.  Natural Peptides Inducing Cancer Cell Death: Mechanisms and Properties of Specific Candidates for Cancer Therapeutics.

Authors:  Plinio A Trinidad-Calderón; Carlos Daniel Varela-Chinchilla; Silverio García-Lara
Journal:  Molecules       Date:  2021-12-09       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.